KeyBanc analyst Aleksey Yefremov lowered the firm’s price target on Livent to $34 from $35 and keeps an Overweight rating on the shares. The firm maintains a bullish stance on Livent and the lithium market following the Q2 print, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on LTHM: